To further test this hypothesis that compensating increases of other protease inhibitor concentrations occur in cases with inherited AAT deficiency, we determined plasma AAT, ACT and SLPI levels in different age groups of healthy and COPD adult subjects with and without AAT deficiency. The gene discussed is SERPINA3; the disease is alpha 1-antitrypsin deficiency.